Pulmonary hypertension in older children: New approaches and therapies

Paediatric Respiratory Reviews

Volumn 7, Issue SUPPL. 1, 2006, Pages

  Abman, Steven H ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMBRISENTAN; AMLODIPINE; BOSENTAN; CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR ANTAGONIST; ILOPROST; NIFEDIPINE; NITRIC OXIDE; OXYGEN; PHOSPHODIESTERASE V INHIBITOR; PLACEBO; PROSTACYCLIN; PROSTACYCLIN DERIVATIVE; SILDENAFIL; SITAXSENTAN; UNIPROST; VASODILATOR AGENT; VERAPAMIL;

CHILD; CHILD HEALTH CARE; CLINICAL ASSESSMENT; CLINICAL TRIAL; DIARRHEA; DISEASE EXACERBATION; DRUG ERUPTION; DYSPEPSIA; ECHOCARDIOGRAPHY; FLUSHING; HEART CATHETERIZATION; HUMAN; INJECTION SITE PAIN; LUNG FUNCTION TEST; NON INVASIVE MEASUREMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; QUALITY OF LIFE; REVIEW; SIDE EFFECT; TREATMENT PLANNING;

3',5'-CYCLIC-GMP PHOSPHODIESTERASE; ANTIHYPERTENSIVE AGENTS; CALCIUM CHANNEL BLOCKERS; CHILD; ECHOCARDIOGRAPHY; EPOPROSTENOL; HEART CATHETERIZATION; HUMANS; HYPERTENSION, PULMONARY; ISOXAZOLES; PHOSPHODIESTERASE INHIBITORS; PULMONARY WEDGE PRESSURE; RECEPTORS, ENDOTHELIN; SULFONAMIDES; THIOPHENES; TREATMENT OUTCOME;

EID: 33745183565     PISSN: 15260542     EISSN: 15260550     Source Type: Journal    
DOI: 10.1016/j.prrv.2006.04.210     Document Type: Review

References (17)

1. Badesch D.B., Abman S.H., Ahearn G.S., et al. Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 126 (2004) 35S-62S
2. Humbert M., Sitbon O., and Simonneau G. Treatment of pulmonary arterial hypertension. N Engl J Med 351 (2004) 1425-1436
3. Rubin L.J., and Badesch D.B. Evaluation and management of the patient with pulmonary arterial hypertension. Ann Intern Med 143 (2005) 282-292
4. Sitbon O., Humbert M., Jais X., et al. Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension. Circulation 111 (2005) 3105-3111
5. Galie N., Ghofrani H.A., Torbicki A., et al. Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med 353 (2005) 2148-2157
6. Humpl T., Reyes J.T., Holtby H., et al. Beneficial effect of chronic sildenafil therapy on childhood pulmonary arterial hypertension. Circulation 111 (2005) 3274-3280
7. Barst R.J., Rubin L.J., Long W.A., et al. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. The Primary Pulmonary Hypertension Study Group. N Engl J Med 334 (1996) 296-302
8. Badesch D.B., Tapson V.F., McGoon M.D., et al. Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial. Ann Intern Med 132 (2000) 425-434
9. Sitbon O., Humbert M., Nunes H., et al. Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival. J Am Coll Cardiol 40 (2002) 780-788
10. McLaughlin V.V., Shillington A., and Rich S. Survival in primary pulmonary hypertension: the impact of epoprostenol therapy. Circulation 106 (2002) 1477-1482
11. Simonneau G., Barst R.J., Galie N., et al. Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial. Am J Respir Crit Care Med 165 (2002) 800-804
12. Tapson VF G-MM, Mclaughlin V, Benza RL, Widlitz A, Krichman A, Barst R. Safety and efficacy of intravenous treprostinil for pulmonary arterial hypertension: A prospective, multicenter, open-label 12-week trial. Chest 2006 (in press).
13. Olschewski H., Simonneau G., Galie N., et al. Inhaled iloprost for severe pulmonary hypertension. N Engl J Med 347 (2002) 322-329
14. Rubin L.J., Badesch D.B., Barst R.J., et al. Bosentan therapy for pulmonary arterial hypertension. N Engl J Med 346 (2002) 896-903
15. Rosenzweig E.B., Ivy D.D., Widlitz A., et al. Effects of long-term bosentan in children with pulmonary arterial hypertension. J Am Coll Cardiol 46 (2005) 697-704
16. Barst R.J., Langleben D., Frost A., et al. Sitaxsentan therapy for pulmonary arterial hypertension. Am J Respir Crit Care Med 169 (2004) 441-447
17. Galie N., Badesch D., Oudiz R., et al. Ambrisentan therapy for pulmonary arterial hypertension. J Am Coll Cardiol 46 (2005) 529-535